Clinical trials, adaptability and the COVID-19 pandemic

Clinical trials, adaptability and the COVID-19 pandemic

Despite the impact of the COVD-19 pandemic and public health crisis on health care delivery, the GOG-Foundation has continued to prioritize the delivery of novel and state-of-the-science treatment options to patients via clinical trials.

Bibliographic Details
Main Authors: Ramez N. Eskander, Bhavana Pothuri, Leslie Randall, David O'Malley, Brian Slomovitz, Kathleen Moore, Robert Coleman, Thomas Herzog, Bradley J. Monk, Larry Copeland
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:Gynecologic Oncology Reports
Subjects:
Gynecologic cancer
Clinical trials
COVID-19
Pandemic
Adaptability
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578920301466
Description
Summary:Despite the impact of the COVD-19 pandemic and public health crisis on health care delivery, the GOG-Foundation has continued to prioritize the delivery of novel and state-of-the-science treatment options to patients via clinical trials.
ISSN:2352-5789

Similar Items